---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-006564"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2025-02-20T23:59:59+00:00"
generated_at: "2026-05-26T08:28:53.334841+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ardelyx reports FY2024 revenue $333.6M; narrows net loss to $39.1M; provides 2025 guidance

## Summary
- Total revenue $333.6M in 2024, up from $124.5M in 2023; driven by IBSRELA ($158.3M) and XPHOZAH ($160.9M) sales.
- Net loss narrowed to $39.1M ($0.17 per share) from $66.1M ($0.30 per share) in 2023.
- Cash and investments ended at $250.1M; drew $49.7M under term loan in Q4 2024.
- IBSRELA 2025 net sales guidance: $240–250M; reaffirmed peak combined sales potential of $1.75B.
- SG&A expenses rose to $258.7M from $134.4M due to sales team expansion and XPHOZAH launch.

## SEC filing metadata
- accession: 0001628280-25-006564
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2025-02-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000162828025006564/0001628280-25-006564-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000162828025006564/ardx-20250220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-006564
- JSON: https://secwatch.observer/filing/0001628280-25-006564.json
- Plain text: https://secwatch.observer/filing/0001628280-25-006564.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.